Characteristics | N | % |
---|---|---|
Total | 158 | 100 |
Age (years, mean ± standard deviation [SD]) | 59.06 ± 11.63 |  |
Gender | ||
 Male | 104 | 66 |
 Female | 54 | 34 |
BMI (kg/m2, mean, SD) | 22.20 ± 3.22 |  |
Tumor location | ||
 Upper | 45 | 28 |
 Middle | 33 | 21 |
 Low | 74 | 47 |
 Across | 6 | 4 |
Lauren Type | ||
 Intestinal | 54 | 34 |
 Diffuse | 75 | 16 |
 Mix | 26 | 47 |
 Missing | 3 | 2 |
Tumor Differentiation | ||
 High | 7 | 4 |
 Moderate | 30 | 19 |
 Poor | 119 | 75 |
 Missing | 2 | 1 |
Depth of tumor invasion | ||
 pT1 | 21 | 13 |
 pT2 | 28 | 18 |
 pT3 | 36 | 23 |
 pT4 | 73 | 46 |
Lymph node metastasis | ||
 pN0 | 52 | 33 |
 pN1 | 23 | 15 |
 pN2 | 24 | 15 |
 pN3 | 59 | 37 |
Distant metastasis | ||
 M0 | 143 | 91 |
 M1 | 15 | 9 |
Postoperative chemotherapy | ||
 Yes | 98 | 62 |
 No | 60 | 38 |
pTNM stage | ||
 I | 36 | 23 |
 II | 36 | 23 |
 III | 71 | 45 |
 IV | 15 | 9 |
Perineural invasion (S-100) | ||
 Positive | 101 | 64 |
 Negative | 52 | 33 |
 Missing | 5 | 3 |
Lymphatic invasion (D2-40) | ||
 Positive | 81 | 51 |
 Negative | 72 | 46 |
 Missing | 5 | 3 |
Venous invasion (CD31) | ||
 Positive | 68 | 43 |
 Negative | 85 | 54 |
 Missing | 5 | 3 |
HER2 | ||
 0 | 83 | 53 |
 1 +  | 41 | 26 |
 2 +  | 22 | 14 |
 3 +  | 8 | 5 |
 Missing | 4 | 3 |
Preoperative CEA (ug/L) | ||
 ≤ 5 | 130 | 82 |
 > 5 | 24 | 15 |
 Missing | 4 | 3 |
Preoperative CA199 (U/ml) | ||
 ≤ 37 | 139 | 88 |
 > 37 | 15 | 9 |
 Missing | 4 | 3 |